Skip to content

Study · Not a test of the peptide alone · 2015

8 results

Stability of peptide drugs in the colon.

Wang J, Yadav V, Smart AL, Tajiri S, Basit AW

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences23 Jun 2015Cited by 43 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study8

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone8

In this study, the peptide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking the peptide.

  1. 01LabNot a test of Goserelin aloneIn vitro (cells)Activity measurement

    In lab tests, goserelin degraded more slowly than the rapidly metabolized larger peptides in a colonic model.

    In plain wordsIn lab tests, goserelin degraded more slowly than larger peptides in a colonic model.

    Peptide
    Goserelin
    Outcome
    DecreaseColonic degradation
    Study

    n: not reported in source

    Mixed human faecal bacteria model
    Comparator
    Larger peptides: insulin, calcitonin, somatostatin, glucagon and secretin
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In contrast, a number of the smaller peptides - Arg-vasopressin, desmopressin, oxytocin, gonadorelin, goserelin, buserelin, leuprolide, nafarelin and deslorelin - degraded more slowly, while octreotide, histrelin and ciclosporin were seen to be more stable as compared to the other small peptides und…
    2 context sentences
    Summary · context
    Of these, the larger peptides - insulin, calcitonin, somatostatin, glucagon and secretin - were metabolized rapidly, with complete degradation observed within 5 min.
    Summary · context
    This study was the first to investigate the colonic stability of 17 peptide molecules (insulin, calcitonin, glucagon, secretin, somatostatin, desmopressin, oxytocin, Arg-vasopressin, octreotide, ciclosporin, leuprolide, nafarelin, buserelin, histrelin, [D-Ser(4)]-gonadorelin, deslorelin, and goserel…

    In this study, Goserelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Goserelin.

  2. 02LabNot a test of Nafarelin aloneIn vitro (cells)Activity measurement

    In lab tests, nafarelin degraded more slowly than the rapidly metabolized larger peptides in a colonic model.

    In plain wordsIn lab tests, nafarelin degraded more slowly than larger peptides in a colonic model.

    Peptide
    Nafarelin
    Outcome
    DecreaseColonic degradation
    Study

    n: not reported in source

    Mixed human faecal bacteria model
    Comparator
    Larger peptides: insulin, calcitonin, somatostatin, glucagon and secretin
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In contrast, a number of the smaller peptides - Arg-vasopressin, desmopressin, oxytocin, gonadorelin, goserelin, buserelin, leuprolide, nafarelin and deslorelin - degraded more slowly, while octreotide, histrelin and ciclosporin were seen to be more stable as compared to the other small peptides und…
    2 context sentences
    Summary · context
    Of these, the larger peptides - insulin, calcitonin, somatostatin, glucagon and secretin - were metabolized rapidly, with complete degradation observed within 5 min.
    Summary · context
    This study was the first to investigate the colonic stability of 17 peptide molecules (insulin, calcitonin, glucagon, secretin, somatostatin, desmopressin, oxytocin, Arg-vasopressin, octreotide, ciclosporin, leuprolide, nafarelin, buserelin, histrelin, [D-Ser(4)]-gonadorelin, deslorelin, and goserel…

    In this study, Nafarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Nafarelin.

  3. 03LabNot a test of Oxytocin aloneIn vitro (cells)Activity measurement

    In lab tests, oxytocin degraded more slowly than the rapidly metabolized larger peptides in a colonic model.

    In plain wordsIn lab tests, oxytocin degraded more slowly than larger peptides in a colonic model.

    Peptide
    Oxytocin
    Outcome
    DecreaseColonic degradation
    Study

    n: not reported in source

    Mixed human faecal bacteria model
    Comparator
    Larger peptides: insulin, calcitonin, somatostatin, glucagon and secretin
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In contrast, a number of the smaller peptides - Arg-vasopressin, desmopressin, oxytocin, gonadorelin, goserelin, buserelin, leuprolide, nafarelin and deslorelin - degraded more slowly, while octreotide, histrelin and ciclosporin were seen to be more stable as compared to the other small peptides und…
    2 context sentences
    Summary · context
    Of these, the larger peptides - insulin, calcitonin, somatostatin, glucagon and secretin - were metabolized rapidly, with complete degradation observed within 5 min.
    Summary · context
    This study was the first to investigate the colonic stability of 17 peptide molecules (insulin, calcitonin, glucagon, secretin, somatostatin, desmopressin, oxytocin, Arg-vasopressin, octreotide, ciclosporin, leuprolide, nafarelin, buserelin, histrelin, [D-Ser(4)]-gonadorelin, deslorelin, and goserel…

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  4. 04LabNot a test of Histrelin aloneIn vitro (cells)Activity measurement

    In lab tests, histrelin was more stable than other small peptides under the same colonic conditions.

    In plain wordsIn lab tests, histrelin was more stable than other small peptides under the same colonic conditions.

    Peptide
    Histrelin
    Outcome
    IncreaseColonic stability
    Study

    n: not reported in source

    Mixed human faecal bacteria model
    Comparator
    Other small peptides
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In contrast, a number of the smaller peptides - Arg-vasopressin, desmopressin, oxytocin, gonadorelin, goserelin, buserelin, leuprolide, nafarelin and deslorelin - degraded more slowly, while octreotide, histrelin and ciclosporin were seen to be more stable as compared to the other small peptides und…
    1 context sentence
    Summary · context
    This study was the first to investigate the colonic stability of 17 peptide molecules (insulin, calcitonin, glucagon, secretin, somatostatin, desmopressin, oxytocin, Arg-vasopressin, octreotide, ciclosporin, leuprolide, nafarelin, buserelin, histrelin, [D-Ser(4)]-gonadorelin, deslorelin, and goserel…

    In this study, Histrelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Histrelin.

  5. 05LabNot a test of Goserelin aloneIn vitro (cell-free)Activity measurement

    In lab tests, goserelin was stable without human faecal bacteria.

    In plain wordsIn lab tests, goserelin was stable without human faecal bacteria.

    Peptide
    Goserelin
    Outcome
    Direction not reportedStability without bacteria
    Study

    n: not reported in source

    Colonic model without human faecal bacteria
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In the absence of human faecal bacteria, all peptides were stable.

    In this study, Goserelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Goserelin.

  6. 06LabNot a test of Histrelin aloneIn vitro (cell-free)Activity measurement

    In lab tests, histrelin was stable without human faecal bacteria.

    In plain wordsIn lab tests, histrelin was stable without human faecal bacteria.

    Peptide
    Histrelin
    Outcome
    Direction not reportedStability without bacteria
    Study

    n: not reported in source

    Colonic model without human faecal bacteria
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In the absence of human faecal bacteria, all peptides were stable.

    In this study, Histrelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Histrelin.

  7. 07LabNot a test of Nafarelin aloneIn vitro (cell-free)Activity measurement

    In lab tests, nafarelin was stable without human faecal bacteria.

    In plain wordsIn lab tests, nafarelin was stable without human faecal bacteria.

    Peptide
    Nafarelin
    Outcome
    Direction not reportedStability without bacteria
    Study

    n: not reported in source

    Colonic model without human faecal bacteria
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In the absence of human faecal bacteria, all peptides were stable.

    In this study, Nafarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Nafarelin.

  8. 08LabNot a test of Oxytocin aloneIn vitro (cell-free)Activity measurement

    In lab tests, oxytocin was stable without human faecal bacteria.

    In plain wordsIn lab tests, oxytocin was stable without human faecal bacteria.

    Peptide
    Oxytocin
    Outcome
    Direction not reportedStability without bacteria
    Study

    n: not reported in source

    Colonic model without human faecal bacteria
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    In the absence of human faecal bacteria, all peptides were stable.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 5Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Versions 2 to 4

    27 Oct 2026, 16:36 UTC

    The same notice was added 3 times, first on 27 Oct 2026, 16:35 UTC. The status did not change between them.

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.